Menu Search
Equities

Carebook Technologies Inc

CRBKF:PKC

Carebook Technologies Inc

Actions
  • Price (USD)0.1144
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Carebook Technologies Inc. is a Canada-based company. The principal activities of the Company consist of the development and commercialization of complete end-to-end digital health platforms that feature assessments, reporting, and targeted solutions offered through an array of selected partners and resellers, or directly to its primary end customers, which are employers across a variety of industries and pharmacies. The Carebook platforms connect about 3.5 million members to a host of healthcare solutions and providers. It offers pharmacy retailers an all-in-one customer-facing digital platform that brings together medication management, the ability for individuals, families, and caregivers to manage their health information in one spot, health assessments, as well as receive recommendations based on their results to help reduce the risk of chronic diseases, including access to health professional services. Wellness Checkpoint Solution and CoreHealth Solution are its products.

  • Revenue in CAD (TTM)14.34m
  • Net income in CAD-3.18m
  • Incorporated2018
  • Employees49.00
  • Location
    Carebook Technologies Inc1400-2045 Stanley St.MONTREAL H3A 2V4CanadaCAN
  • Phone+1 (514) 499-2848
  • Fax+1 (514) 845-9178
  • Websitehttps://carebook.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.